Pulsavac Plus System
Navigation Links
Pulsavac Plus System
| Products | Pulsavac Plus System |
| Company | Zimmer, Inc. |
| Item | Pulsavac Plus System |
| Features |
|
| Description | The Pulsavac Plus System offers a disposable alternative to the proven Pulsavac Wound Debridement System. High power efficiently clears bone and cement debris during total joint procedures. Specific tips are available for hip and knee applications. Variety of tips provide a wide range of pressure options for soft tissue treatment. Low power setting provides gentle lavage to help remove necrotic tissue and facilitate healing. |
| Info | Zimmer, Inc. Customer Service: (800) 613-6131 Web site: http://www.zimmer.com |
Related medicine products :
1. Pulsavac Wound Debridement System
2. Silicone Oil Cannula System - 20 Gauge
3. Silicone Oil Cannula System - 19 Gauge
4. SuperVu Galilean System
5. KOWA nonmyd 7 / VK-2 Digital Imaging System
6. KOWA nonmyd a-D / VK-2 Digital Imaging System
7. Refraction System RT-2100
8. Odyssey Phacoemulsification System
9. SIStem Phacoemulsification System
10. Precisionist Phacoemulsification System
11. Photon Laser Phacoemulsification System
Breaking Medicine News(10 mins):Health News:UNFPA Honoured With Human Rights Award 2Health News:UNFPA Honoured With Human Rights Award 3Health News:FEHBP Open Enrollment Period to be Discussed on Special Rebroadcast of 'Inside Government' 2Health News:Weight Watchers Declares Quarterly Dividend 2Health News:New Field of 'Cardio-oncology' Suggested 2Health News:Major New Study Finds Soyfoods Safe and Beneficial for Women With Breast Cancer 2
[0] UNFPA Honoured With Human Rights Award[0] FEHBP Open Enrollment Period to be Discussed on Special Rebroadcast of 'Inside Government'[0] Weight Watchers Declares Quarterly Dividend[0] New Field of 'Cardio-oncology' Suggested[0] Major New Study Finds Soyfoods Safe and Beneficial for Women With Breast Cancer
Other Medicine News:Health News:Eastern Insurance Holdings, Inc. Announces Definitive Agreement to Acquire Employers Security Holding Company and Subsidiaries 2Health News:Eastern Insurance Holdings, Inc. Announces Definitive Agreement to Acquire Employers Security Holding Company and Subsidiaries 3Health News:Eastern Insurance Holdings, Inc. Announces Definitive Agreement to Acquire Employers Security Holding Company and Subsidiaries 4Health News:Medical Blogs May Threaten Patient Privacy 2Health News:Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients 2Health News:Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients 3Health News:Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients 4Health News:Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients 5Health News:Vapotherm(R) Precision Flow(TM) Receives FDA 510(k) Clearance 2Health News:Consumers, Nurses, Seniors Tell Governor: Don't Break Your Promise to Protect Innocent Patients from Health Insurance Cancellations, Don't Weaken Existing Law 2Health News:Consumers, Nurses, Seniors Tell Governor: Don't Break Your Promise to Protect Innocent Patients from Health Insurance Cancellations, Don't Weaken Existing Law 3Health News:Consumers, Nurses, Seniors Tell Governor: Don't Break Your Promise to Protect Innocent Patients from Health Insurance Cancellations, Don't Weaken Existing Law 4Health News:Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads 2Health News:Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads 3Health News:Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads 4Health News:Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads 5Health News:Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads 6
Eastern Insurance Holdings, Inc. Announces Definitive Agreement to Acquire Employers Security Holding Company and SubsidiariesMedical Blogs May Threaten Patient PrivacyHead-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive PatientsVapotherm(R) Precision Flow(TM) Receives FDA 510(k) ClearanceConsumers, Nurses, Seniors Tell Governor: Don't Break Your Promise to Protect Innocent Patients from Health Insurance Cancellations, Don't Weaken Existing LawAnalysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads
Breaking Medicine Technology:China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18Vivakor Announces New Acquisition Strategy 2General anesthetics lead to learning disabilities in animal models 59954 1General anesthetics lead to learning disabilities in animal models 59954 2General anesthetics lead to learning disabilities in animal models 59954 3New artificial enzyme safer for nature 10482 1New artificial enzyme safer for nature 10482 2Now hear this 10478 1
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |